It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
You are hereby granted a non-exclusive, limited, and revocable license to access this Site. Sandoz SA reserves the right to revoke this license generally, or your right of access, at any time. If Sandoz SA revokes this license, you agree to discontinue using this Site immediately. The accessibility and availability of this Site will always be at the absolute discretion of Sandoz SA.
You agree not to present the link to this Site in such a way that it is associated with advertising or appears to be an endorsement of any organization, product, or service. You agree that the link will not appear on a website that a reasonable person may consider obscene, defamatory, harassing, grossly offensive, or malicious. Under no circumstances may you "frame" this Site or any of its content or copy portions of this Site to a server. You agree not to display or use the Sandoz SA logo or trademark in any manner without our prior written permission.
THESE THIRD-PARTY WEBSITES MAY CONTAIN INFORMATION ABOUT USES OF SANDOZ SA PRODUCTS OR THERAPIES THAT HAVE NOT BEEN APPROVED IN THE COUNTRY WHERE YOU RESIDE. WE DO NOT CONTROL OR ENDORSE THIS TYPE OF INFORMATION.
Although Sandoz SA may, from time to time, monitor or review discussions, chats, postings, transmissions, message boards, and the like (“Content”) on or related to the Site, Sandoz SA is under no obligation to do so. Sandoz SA assumes no responsibility or liability arising from the Content nor for any error, defamation, omission, false information, promotional materials, obscenity, pornography, profanity, danger, privacy disclosure or inaccuracy contained in any Content shared via or related to the Site. You are prohibited from posting or transmitting any unlawful, which may include, but is not limited to promotional, threatening, defamatory, obscene, scandalous, inflammatory, pornographic, or profane material or any material that could constitute or encourage conduct that would be considered a criminal offence, give rise to civil liability, or otherwise violate any law. Sandoz SA will fully cooperate with any law enforcement authorities or court order requesting or directing Sandoz SA to disclose the identity of anyone posting any such information or materials.
You may not misuse the Site in any manner which includes attempting to override any security feature of the Site, interfering with the functionality of the Site or attempting to access the Site using any method other than the interface provided to you.
This Site contains information about products and therapies authorized in South Africa and is intended to be viewed by residents of South Africa. If you live outside South Africa, you may see information on this Site about products or therapies that are not available or authorized in your country of residence. The products referred to on this Site may be subject to different regulatory requirements depending on the country of use. Consequently, visitors may be notified that certain sections of this Site are intended only for healthcare providers or only for certain users or certain countries. You should not construe anything on this Site as a promotion or advertisement for any product or for the use of any product that is not authorized by the laws and regulations of your country of residence.
The materials on this Site belong to or are licensed to Sandoz SA or another Novartis group company and are subject to applicable copyright laws. You may freely surf the Site, but you may only access, download or use information from this Site, including any text, images, audio, and video (the "Information") for your own non-commercial use. You may not distribute, modify, transmit, reuse, repost, or use the Information for commercial purposes, without written permission of Sandoz SA. You must retain and reproduce each and every copyright notice or other proprietary rights notice contained in any Information you download.
Unless otherwise noted, you should assume that any logos, company names or trade names appearing on this Site are trademarks of Sandoz SA, other Novartis group companies and/or other parties. This Site may also contain or reference patents, proprietary information, technologies, products, processes or other proprietary rights of Sandoz SA and / or other parties (“Trademarks”). No license to or right in any such Trademarks is granted to or conferred upon you.
Any information on this Site is provided by Sandoz SA and is intended for general information purposes only. It is not intended to provide complete medical information and cannot replace the relationship that you have with your healthcare professional. Many pharmaceutical and medical device products listed are available when appropriate on prescription from a medical doctor or qualified medical professional only. The services or advice and the information on this Site should not be considered medical advice. You should always talk to your healthcare professional for diagnosis and treatment. SHOULD YOU HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN MEDICAL DOCTOR OR HEALTHCARE PROVIDER. WE DO NOT OFFER PERSONALIZED MEDICAL DIAGNOSIS OR PATIENT-SPECIFIC TREATMENT ADVICE.
If you believe that you have experienced any adverse events from a Sandoz SA product you should consult your physician, pharmacist or other healthcare provider immediately. You can also report these to us directly by visiting https://www.report.novartis.com/. Should you report any adverse events, Sandoz SA may need to contact you to find out more information and request consent to collect additional information. Data of this nature will not appear on this Site, in order to fulfill legal obligations concerning drug safety reporting, while maintaining your confidentiality. In case of an adverse event or product issue we may need to store information about you on an anonymized basis, such as your demographic information. This information is required to be submitted to the Novartis Patient Safety department and / or Regulatory Authorities and / or License Partners.
Sandoz SA may deliver notice to you by electronic mail, a general notice on this Site, or by written communication delivered by post to your address on record with Sandoz SA. You may deliver notice to Sandoz SA via electronic mail to [email protected]
[S1] ACC® 600 (effervescent tablets). Reg. No.: 45/10.3/0229. Composition: Each effervescent tablet contains 600 mg acetylcysteine. ATC Code: R05CB01.ACC® Oral Solution
[S1] ACC® 20 mg/ml Oral Solution. Reg. No.: 48/10.3/0261. Composition: Each 1 ml of ACC 20 mg/ml ORAL SOLUTION contains 20 mg acetylcysteine. ATC Code: R05CB01.ACC® 200
[S1] ACC® 200 (effervescent tablets). Reg. No.: 29/10.2.2/0753. Composition: Each ACC 200 effervescent tablet contains: 200 mg acetylcysteine. Pharmacological Classification: A10.3 Medicines acting on the respiratory system – other.
For full prescribing information refer to the Sandoz Professional Information approved by the South African Health Products Regulatory Authority (SAHPRA).
Sandoz SA (Pty) Ltd, Reg. No. 1990/001979/07,
Magwa Crescent West,
Tel: +27 (11) 347 6600.
SANCAL Customer Call Centre: 0861 726 225.
Reporting of AEs: https://www.report.novartis.com